Home > Insider Trading > Ligand Pharmaceuticals Inc

Ligand Pharmaceuticals Inc (LGND)

Market is closed

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

News

First
<< Previous
11 - 20
Next >>

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2022 Earnings Call Transcript

Operator: Good evening. My name is Rob and I will be your conference operator today. At this time, I would like to welcome everyone to the Ligand Pharmaceuticals Fourth Quarter 2022 Earnings Webcast.

Keep Reading →

March 1st, 2023 - News Transcripts

15 Most Volatile Stocks to Buy Now

Even though the United States stock market is inextricably linked to the US economy, there are increased fears that the factors contributing to the decline of both in the past few months are vastly different...

Keep Reading →

November 21st, 2022 - Hedge Funds News

Should You Consider Investing in Ligand Pharmaceuticals (LGND)?

Bumbershoot Holdings LP, an investment management firm, published its third-quarter 2021 investor letter – a copy of which can be downloaded here. Bumbershoot Holdings L.P.

Keep Reading →

March 22nd, 2022 - Hedge Fund Investor Letters News

Hedge Fund and Insider Trading News: Michael Burry, Chris Hohn, Fortress Investment Group, Magnetar Capital, Verde Asset Management, Lemelson Capital Management, Evli Factor Premia Fund, Renovacor Inc (RCOR), Assurant, Inc. (AIZ), and More

NEW YORK--(BUSINESS WIRE)-- Fortress Investment Group LLC (“Fortress”) was named the recipient of the inaugural “Diversity and Inclusion Achievement” award at the 2021 HFM US Performance Awards...

Keep Reading →

November 10th, 2021 - Hedge Funds Insider Trading

Here's Why Ligand Pharmaceuticals (LGND) Became Wasatch Global's Q1 2021 Top Contributor

Wasatch Global Investors, an investment management firm, published its “Wasatch Core Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.

Keep Reading →

May 10th, 2021 - Hedge Fund Investor Letters News

Is LGND A Good Stock To Buy According To Hedge Funds?

We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...

Keep Reading →

December 18th, 2020 - Hedge Funds News

4 Health Stocks Stonepine Capital Loves (1 Has Gained 233% Since September 29)

Timothy P. Lynch’s Stonepine Capital is a life science-focused hedge fund that seeks to utilize its industry experience to uncover undervalued and under-the-radar health companies.

Keep Reading →

October 26th, 2020 - Hedge Fund Analysis Hedge Funds News

Should I Avoid Ligand Pharmaceuticals Inc. (LGND)?

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).

Keep Reading →

October 6th, 2020 - Hedge Funds News

Were Hedge Funds Right About Ligand Pharmaceuticals Inc. (LGND)?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Keep Reading →

July 12th, 2020 - Hedge Funds News